Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (NASDAQ:SLNO) is one of the 17 biotechnology stocks with more than 50% upside. On January 20, the price target on Soleno Therapeutics (NASDAQ:SLNO) was increased from $110 to $120 by Ram Selvaraju from H.C. Wainwright. He also reaffirmed his Buy rating on the stock, which, as per his forecasts, offers an upside potential of almost 211%. The analyst based his rating on the company’s impressive sales figures, which continue to beat estimates. Likoper/Shutterstock.com On January 20, We ...